We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $579M
1-Year Est. Return 94.36%
This Fund
S&P 500
This Quarter Est. Return
+40.48%
1 Year Est. Return
+94.36%
3 Year Est. Return
+196.81%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$565M
AUM Growth
+$183M
Cap. Flow
+$64.7M
Cap. Flow %
11.44%
Top 10 Hldgs %
66.34%
Holding
79
New
22
Increased
9
Reduced
6
Closed
5

Top Buys

1
RPRX icon
Royalty Pharma
RPRX
+$55.2M
2
EOSE icon
Eos Energy Enterprises
EOSE
+$5.07M
3
LIQT icon
LiqTech
LIQT
+$4.94M
4
LSXMA
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
+$3.45M
5
FATE icon
Fate Therapeutics
FATE
+$2.39M

Top Sells

1
WELL icon
Welltower
WELL
+$6.7M
2
FLNA
Filana Therapeutics
FLNA
+$3.13M
3
PYPL icon
PayPal
PYPL
+$2.42M
4
IHC
Independence Holding Company
IHC
+$1.12M
5
RTN
Raytheon Company
RTN
+$566K

Sector Composition

1 Healthcare 26.02%
2 Industrials 14.54%
3 Energy 11.06%
4 Consumer Discretionary 9.17%
5 Materials 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RTX icon
51
RTX Corp
RTX
$262B
$370K 0.07%
+6,000
New +$374K
XFOR icon
52
X4 Pharmaceuticals
XFOR
$361M
$333K 0.06%
1,191
– –
LHX icon
53
L3Harris
LHX
$53B
$271K 0.05%
1,600
– –
VATE icon
54
INNOVATE Corp
VATE
$128M
$239K 0.04%
7,154
– –
INFI
55
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$226K 0.04%
250,000
-250,000
-50% -$238K
BATRA icon
56
Atlanta Braves Holdings Series A
BATRA
$3.7B
$208K 0.04%
10,356
– –
PHYS icon
57
Sprott Physical Gold
PHYS
$14.3B
$179K 0.03%
12,540
– –
OTIS icon
58
Otis Worldwide
OTIS
$28.8B
$171K 0.03%
+3,000
New +$155K
CARR icon
59
Carrier Global
CARR
$57.6B
$133K 0.02%
+6,000
New +$111K
LILAK icon
60
Liberty Latin America Class C
LILAK
$1.5B
$115K 0.02%
+14,212
New +$121K
LGF.B
61
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$112K 0.02%
16,413
– –
BNY
62
Bank of New York Mellon
BNY
$110B
$77K 0.01%
2,000
– –
LITE icon
63
Lumentum
LITE
$54.9B
$54K 0.01%
+660
New +$50.3K
XLNX
64
DELISTED
Xilinx Inc
XLNX
$52K 0.01%
+530
New +$47K
ABBV icon
65
AbbVie
ABBV
$449B
$51K 0.01%
+515
New +$45.3K
TER icon
66
Teradyne
TER
$50.5B
$51K 0.01%
+600
New +$40.2K
CDNS icon
67
Cadence Design Systems
CDNS
$101B
$50K 0.01%
+525
New +$43.9K
T icon
68
AT&T
T
$153B
$50K 0.01%
+2,185
New +$49.8K
XOM icon
69
ExxonMobil
XOM
$605B
$48K 0.01%
+1,075
New +$48.2K
MO icon
70
Altria Group
MO
$122B
$47K 0.01%
+1,200
New +$46.8K
LILA icon
71
Liberty Latin America Class A
LILA
$1.51B
$39K 0.01%
6,274
– –
PRGX
72
DELISTED
PRGX Global, Inc.
PRGX
$37K 0.01%
+7,938
New +$28.5K
ADEA icon
73
Adeia
ADEA
$2.86B
$1K ﹤0.01%
+340
New +$1.29K
AVNW icon
74
Aviat Networks
AVNW
$268M
$1K ﹤0.01%
+66
New +$412
MTB icon
75
M&T Bank
MTB
$36.8B
– –
-5,274
Closed -$545K
1 2
3
4

Similar funds

BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
LRIA
Leonard Rickey Investment Advisors Yakima, Washington $578M AUM 16.23% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
GCM
Gibraltar Capital Management Tulsa, Oklahoma $581M AUM 18.65% 1-Year Est. Return
KNW
Kesler Norman & Wride Ogden, Utah $581M AUM 17.6% 1-Year Est. Return

Bleichroeder LP's Q2 2020 Portfolio in Review

As of Q2 2020, Bleichroeder LP held 79 positions worth $565M, up 48% from $383M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Bleichroeder LP deployed $64.7M of net new capital in Q2 2020, opening 22 new positions and adding to 9 existing holdings. Its largest new stake was Royalty Pharma: 1,115,980 shares worth $54.2M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 17% a quarter earlier, followed by Industrials and Energy.

On the sell side, the largest reduction was Filana Therapeutics, an estimated $3.13M trimmed.

  • Bleichroeder LP's largest Q2 2020 buy was Royalty Pharma: 1,115,980 shares worth $54.2M.
  • Bleichroeder LP added most to LiqTech in Q2 2020, an estimated $4.94M increase.
  • Bleichroeder LP's biggest Q2 2020 reduction was Filana Therapeutics, cutting an estimated $3.13M.
  • Bleichroeder LP fully exited Welltower in Q2 2020, selling an estimated $6.7M.
  • Bleichroeder LP's ten largest holdings make up 66% of its $565M portfolio in Q2 2020.
  • Bleichroeder LP opened 22 new positions and closed 5 in Q2 2020.
  • Bleichroeder LP's portfolio value rose 48% quarter-over-quarter to $565M.

Based on Bleichroeder LP's 13F filing for Q2 2020, filed 12 Aug 2020.